Finance

Lists
Why is EHC down 4.82%?
Dive Deeper
EHC:NYSE
Encompass Health Corp
$ 121.71
-4.82%
(-6.16) 1D
$ 121.71
0.00% (0.00)
After hours
Closed: 10-р сарын 19, 16:00:02 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHC...
Open
$ 126.79
High
$ 128.38
Low
$ 121.51
Mkt. cap
12.01 тэрбум
Avg. vol.
910.08 мян
Volume
2.26 сая
Dividend
0.69%
Quarterly dividend
$ 0.21
Ex-dividend date
2026 оны 10-р сарын 1
P/E ratio
19.86
52-wk high
$ 129.96
52-wk low
$ 92.77
EPS
$ 6.13
Beta
0.75
Shares outstanding
98.65 сая
No. of employees
30 мян
Open
$ 126.79
High
$ 128.38
Low
$ 121.51
Mkt. cap
12.01 тэрбум
Avg. vol.
910.08 мян
Volume
2.26 сая
Dividend
0.69%
Quarterly dividend
$ 0.21
Ex-dividend date
2026 оны 10-р сарын 1
P/E ratio
19.86
52-wk high
$ 129.96
52-wk low
$ 92.77
EPS
$ 6.13
Beta
0.75
Shares outstanding
98.65 сая
No. of employees
30 мян
News stories
From web sources and news partners
Profile
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022. From 1996 to 2003, executives at the company committed accounting fraud on a large scale, leading to a scandal and financial restructuring. Wikipedia
About Encompass Health Corp
CEOMark J. Tarr
Employees29.7 мян
Founded1984 оны 2-р сарын 22
HeadquartersБирмингем, Алабама, Америкийн Нэгдсэн Улс
SectorHealth care provider
Analyst ratings
Based on 10 analysts giving stock ratings to EHC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EHC in the last 3 months.
Highest
Current $ 121.71
$ 155.00 (+27.35%)
Average
$ 146.78 (+20.60%)
Lowest
$ 140.00 (+15.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
A.J. Rice
UBS
Buy
Maintained
$ 155.00
+27.4%
10/12/2026
Ryan Langston
TD Cowen
Buy
Maintained
$ 140.00
+15%
10/02/2026
Andrew Cooper
Raymond James
Buy
Reiterated
$ 150.00
+23.2%
09/28/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
$ 142.00
+16.7%
09/18/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$ 147.00
+20.8%
09/17/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$ 140.00
+15%
08/11/2026
David S Macdonald
Truist Financial
Buy
Maintained
$ 150.00
+23.2%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
$ 150.00
+23.2%
08/07/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
$ 153.00
+25.7%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$ 144.00
+18.3%
08/06/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Reiterated
$ 140.00
+15%
05/04/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$ 150.00
+23.2%
05/01/2026
Next call 9 өдрийн дараа
10-р сарын 29. Пү, 16:00
Fiscal period
Q3 2026
- / $ 1.36
Revenue / Est. (USD)
- / 1.60 тэрбум
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.48 тэрбум
1.54 тэрбум
1.59 тэрбум
1.60 тэрбум
Cost of goods sold
849.40 сая
865.60 сая
882.40 сая
886.40 сая
Cost of revenue
849.40 сая
865.60 сая
882.40 сая
886.40 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71.00 сая
88.20 сая
73.40 сая
77.30 сая
Operating expense
384.50 сая
395.60 сая
402.60 сая
422.60 сая
Total operating expenses
1.23 тэрбум
1.26 тэрбум
1.28 тэрбум
1.31 тэрбум
Operating income
243.60 сая
283.40 сая
301.60 сая
288.40 сая
Other non operating income
5.90 сая
3.70 сая
1.20 сая
9.10 сая
EBT including unusual items
219.90 сая
257.70 сая
288.70 сая
261.60 сая
EBT excluding unusual items
219.90 сая
257.70 сая
271.40 сая
264.80 сая
Income tax expense
44.90 сая
55.40 сая
56.40 сая
53.60 сая
Effective tax rate
20.42%
21.50%
19.54%
20.49%
Other operating expenses
231.10 сая
221.00 сая
241.90 сая
254.90 сая
Net income
126.50 сая
146.10 сая
194.50 сая
153.90 сая
Net profit margin
8.56%
9.46%
12.26%
9.63%
Earnings per share
1.23
1.46
1.60
1.55
Interest and investment income
-
-
-
-
Interest expense
-30.80 сая
-30.20 сая
-31.80 сая
-32.80 сая
Net interest expenses
-30.80 сая
-30.20 сая
-31.80 сая
-32.80 сая
Depreciation and amortization charges
82.40 сая
86.40 сая
87.30 сая
90.40 сая
EBITDA
326.00 сая
369.80 сая
388.90 сая
378.80 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс